Seeking Alpha
What is your profession? ×
( followers)

Rob Zenilman submits: Last week’s price movement in the Biotech sector ranged from +3.4% (DNA) to -7.1% (NASDAQ:NABI). IMCL & TELK led week over week volume increases at 8.2% & 1.0%, respectively.

New 52 week highs were made by AMLN ($49.68) & CELG ($48.59).

A new 52 week low was made by AFFX ($25.15).

Key developments that drove individual stocks:

● On June 29th, Celgene (NASDAQ:CELG) announced that the FDA approved Revlimid to treat a certain type of blood cancer.

● On June 26th, Nastech Pharmaceutical (NSTK) announced that they would be working with Amylin Pharmaceuticals (AMLN) to develop a diabetes treatment to be administered via nasal spray.

* View More Biotech Sector Charts *

Data in table version -- click on a ticker for opinion and analysis of the company:

Price Volume
Ticker Company Change Change
AFFXAffymetrix Inc.0.4%
ALXNAlexion Pharmaceuticals Inc.-1.1%
AMGNAmgen Inc.1.8%
AMLNAmylin Pharmaceuticals Inc.-0.7%
BIIBBiogen Idec Inc.-1.4%
BMRNBioMarin Pharmaceutical Inc.2.3%
BSTEBiosite Incorporated1.6%
CELGCelgene Corporation1.7%
DNAGenentech Inc.3.4%
ELNElan Corp. plc-5.3%
GILDGilead Sciences Inc.2.7%
GPROGen-Probe Inc.-0.6%
IMCLImclone Systems Inc.-0.2%
INCYIncyte Corp.-2.4%
ISTAISTA Pharmaceuticals Inc.-6.8%
KOSPKOS Pharmaceuticals Inc.2.4%
MEDIMedImmune Inc.0.6%
NABINabi Biopharmaceuticals-7.1%
NBIXNeurocrine Biosciences Inc.-0.9%
ONXXOnyx Pharmaceuticals Inc.-2.1%
PGNXProgenics Pharmaceuticals Inc.0.6%
PHRMPharmion Corp.-0.6%
TELKTelik Inc.1.5%
VRTXVertex Pharmaceuticals Inc.-2.2%

Data: CapitalIQ


  1. Most recent opinion and analysis of Biotech stocks
  2. Full transcripts of recent conference calls in the Biotech sector
  3. Add the Biotech Stock Blog to your My Yahoo! page

Aside: Did you know that Seeking Alpha now publishes a one-page recap of Jim Cramer's Mad Money stock picks?